EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Metabolomics Insights into the Benefits of SGLT2 Inhibitors in Type 2 Diabetes

Artemis Kyriakidou iD, Theocharis Koufakis iD, Helen Gika iD, Kalliopi Kotsa iD

Clinical Pharmacology: Advances and Applications · 2025-08 · Volume 17 · 253-267

DOI: 10.2147/cpaa.s497906 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2025-08. Verfasst von Artemis Kyriakidou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessalo…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

SGLT-2 inhibitorsmetabolomicstype 2 diabetes mellitus

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece.
  • Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece.
  • Laboratory of Forensic Medicine & Toxicology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

ORCID-Profile: Artemis Kyriakidou, Theocharis Koufakis, Helen Gika, Kalliopi Kotsa

Zitieren

APA

Kyriakidou, A., Koufakis, T., Gika, H., & Kotsa, K. (2025). Metabolomics Insights into the Benefits of SGLT2 Inhibitors in Type 2 Diabetes. Clinical Pharmacology: Advances and Applications, Volume 17, 253-267. https://doi.org/10.2147/cpaa.s497906

Vancouver

Kyriakidou A, Koufakis T, Gika H, Kotsa K. Metabolomics Insights into the Benefits of SGLT2 Inhibitors in Type 2 Diabetes. Clinical Pharmacology: Advances and Applications. 2025;Volume 17:253-267. doi:10.2147/cpaa.s497906

BibTeX
@article{Kyriakidou2025,
  author = {Kyriakidou, Artemis and Koufakis, Theocharis and Gika, Helen and Kotsa, Kalliopi},
  title = {Metabolomics Insights into the Benefits of SGLT2 Inhibitors in Type 2 Diabetes},
  journal = {Clinical Pharmacology: Advances and Applications},
  year = {2025},
  volume = {Volume 17},
  pages = {253--267},
  doi = {10.2147/cpaa.s497906}
}
Kostenlos starten →